Stockreport

Revolution Medicines to Report Financial Results for First Quarter 2026 After Market Close on May 6, 2026

Revolution Medicines, Inc.  (RVMD) 
PDF REDWOOD CITY, Calif., April 29, 2026 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc. (Nasdaq: RVMD), a late-stage clinical oncology company developing targeted therapie [Read more]